BiO2 Medical, Inc. is a medical device manufacturer founded to design, develop, and subsequently manufacture a range of medical products in response to clinical needs.

BiO2 Medical's current primary objective is to develop and commercialize the Angel™ Catheter as the de facto standard of care device for the prevention of Pulmonary Embolism related mortality and morbidity in critically ill patients worldwide. This proven team of technical staff is supported by management and advisors who have worked together for 10 years and have extensive experience in: medical device development, product commercialization, and patent portfolio creation.

In July 2016, BiO2 Medical was granted FDA approval for the Angel™ Catheter; the only productapproved for the prevention of pulmonary embolism in hospitalized patients.